Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
World Journal of Surgical Oncology
Published in: World Journal of Surgical Oncology 1/2013

Open Access 01-12-2013 | Case report

Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of 18F-FDG PET/CT in treatment planning

Authors: Koji Kumagai, Terue Okamura, Masao Toyoda, Hideto Senzaki, Chihiro Watanabe, Masahide Ohmichi

Published in: World Journal of Surgical Oncology | Issue 1/2013

Login to get access

Abstract

Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusively using 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT), and treated by low anterior resection with total mesorectal excision aiming for macroscopic complete resection. The treatment goals for the patient were gradually changed from curative to palliative chemotherapy; she survived for 45 months without rectal obstruction after secondary debulking surgery, and was followed up until autopsy. Thus, 18F-FDG PET/CT may be valuable for detecting rectal lymph node metastasis and can play an essential role in planning treatment for recurrent ovarian carcinoma.
Appendix
Available only for authorised users
Literature
1.
Güth U, Huang DJ, Bauer G, Stieger M, Wight E, Singer G: Metastatic patterns at autopsy in patients with ovarian carcinoma. Cancer. 2007, 110: 1272-1280. 10.1002/cncr.22919.CrossRefPubMed
2.
Bristow RE, Karlan BY, Chi DS: Surgery for Ovarian Cancer: Principles and Practice. 2010, New York: Informa Healthcare, 2CrossRef
3.
Richter R, Feyerabend T: Normal Lymph Node Topography: CT Atlas. 2004, Berlin: SpringerCrossRef
4.
Salani R, Diaz-Montes T, Giuntoli RL, Bristow RE: Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma. Ann Surg Oncol. 2007, 14: 3552-3557. 10.1245/s10434-007-9565-7.CrossRefPubMed
5.
Baiocchi G, Cestari LA, Macedo MP, Oliveira RA, Fukazawa EM, Faloppa CC, Kumagai LY, Badiglian-Filho L, Menezes AN, Cunha IW, Soares FA: Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection. J Surg Oncol. 2011, 104: 250-254. 10.1002/jso.21940.CrossRefPubMed
6.
Galandiuk S, Chaturvedi K, Topor B: Rectal cancer: a compartmental disease, the mesorectum and mesorectal lymph nodes. Recent Results Cancer Res. 2005, 165: 21-29. 10.1007/3-540-27449-9_4.CrossRefPubMed
7.
McMahon CJ, Rofsky NM, Pedrosa I: Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging. Radiology. 2010, 254: 31-46. 10.1148/radiol.2541090361.CrossRefPubMed
8.
Manci N, Bellati F, Graziano M, Pernice M, Muzii L, Angioli R, Benedetti Panici P: Ovarian cancer, diagnosed with PET, with bilateral inguinal lymphadenopathy as primary presenting sign. Gynecol Oncol. 2006, 100: 621-622. 10.1016/j.ygyno.2005.09.026.CrossRefPubMed
9.
Susini T, Olivieri S, Molino C, Castiglione F, Tavella K, Viligiardi R: Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review. J Womens Health. 2010, 19: 169-174. 10.1089/jwh.2009.1465.CrossRef
10.
Lenhard MS, Burges A, Johnson TR, Stieber P, Kümper C, Ditsch N, Linke R, Friese K: PET-CT in recurrent ovarian cancer: impact on treatment planning. Anticancer Res. 2008, 28: 2303-2308.PubMed
11.
Prakash P, Cronin CG, Blake MA: Role of PET/CT in ovarian cancer. AJR Am J Roentogenol. 2010, 194: W464-470. 10.2214/AJR.09.3843.CrossRef
12.
Shreve P, Townsend DW: Clinical PET-CT in Radiology: Integrated Imaging in Oncology. 2010, New York: Springer
13.
Park JY, Seo SS, Kang S, Lee KB, Lim SY, Choi HS, Park SY: The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Gynecol Oncol. 2006, 103: 977-984. 10.1016/j.ygyno.2006.06.004.CrossRefPubMed
14.
Schillaci O: Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity. Semin Nucl Med. 2012, 42: 267-280.CrossRefPubMed
15.
Chan WL, Ramsay SC, Szeto ER, Freund J, Pohlen JM, Tarlinton LC, Young A, Hickey A, Dura RJ: Dual-time-point 18F-FDG-PET/CT imaging in the assessment of suspected malignancy. Med Imaging Radiat Oncol. 2011, 55: 379-390. 10.1111/j.1754-9485.2011.02287.x.CrossRef
16.
Chi DS, McCaughty K, Diaz JP, Huh J, Schwabenbauer S, Hummer AJ, Venkatraman ES, Aghajanian C, Sonoda Y, Abu-Rustum NR, Barakat RR: Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer. 2006, 106: 1933-1939. 10.1002/cncr.21845.CrossRefPubMed
Metadata
Title
Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of 18F-FDG PET/CT in treatment planning
Authors
Koji Kumagai
Terue Okamura
Masao Toyoda
Hideto Senzaki
Chihiro Watanabe
Masahide Ohmichi
Publication date
01-12-2013
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2013
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-11-184

Other articles of this Issue 1/2013

World Journal of Surgical Oncology 1/2013 Go to the issue

Research

Caudate lobe resections: a single-center experience and evaluation of factors predictive of outcomes

Case report

An unexpected but interesting response to a novel therapy for malignant extragastrointestinal stromal tumor of the mesoileum: a case report and review of the literature

Case report

Successful combination chemotherapy with irinotecan hydrochloride and cisplatin for primary gastric small cell carcinoma: report of a case

Case report

Neglected synovial osteochondromatosis of the elbow: a rare case

Research

MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6

Research

Do histopathologic findings improve by increasing the sample size in cholecystectomies?